BioCentury

7:00 AM GMT, Mar 15, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Sutent sunitinib: Phase III data

Data from the open-label Phase III SUN 1064 trial for first-line treatment of advanced HER2-negative breast

Read the full 168 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.